Sort
261,768 grants matching “gene therapy”
GENERAL CLINICAL RESEARCH CENTER
$6,305,686University Of Southern California · M01 · FY2000 · RR
Biology and pathobiology of apoE in aging and Alzheimer's disease
$6,293,390Takahisa Kanekiyo · Mayo Clinic Jacksonville · U19 · FY2025 · AG
Regional Oncology Research Center
$6,292,072Martin D Abeloff · Johns Hopkins University · P30 · FY2006 · CA
Tri-Institutional TB Research Unit: Persistence and Latency
$6,284,115Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2014 · AI
Gene Therapy Platform for Rare Diseases
$6,246,466Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
Stem Cell Translation Laboratory (SCTL)
$6,242,548Carlos Tristan · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Clinical Core
$6,233,431Ziad Nahas · University Of Minnesota · U54 · FY2023 · AT
Regional Oncology Research Center
$6,223,765Johns Hopkins University · P30 · FY2005 · CA
Discovery and validation of genetic variants affecting microglial activation in Alzheimer's disease
$6,213,164Philip L De Jager · Columbia University Health Sciences · RF1 · FY2020 · AG
Defining the effect of Alzheimer pathologies on the aged brain in 3 dimensions
$6,207,555Philip L De Jager · Columbia University Health Sciences · U19 · FY2025 · AG
Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents
$6,164,904Lindsay Morton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
An integrated approach to analyze and target EWS/FLI in Ewing sarcoma
$6,163,485Stephen L Lessnick · Research Inst Nationwide Children'S Hosp · U54 · FY2018 · CA
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
$6,160,778Luis Guillermo Carvajal Carmona · University Of California At Davis · U54 · FY2018 · CA
The CRISPR Vision Program: Nonviral Genome Editing Platforms to Treat Inherited Retinal Channelopathies
$6,159,146Krishanu Saha · University Of Wisconsin-Madison · U19 · FY2023 · NS
The IU/JAX Alzheimer's Disease Precision Models Center
$6,158,485Bruce T Lamb · Indiana University Indianapolis · U54 · FY2020 · AG
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis
$6,151,947James Dale Berry · Massachusetts General Hospital · U01 · FY2025 · NS
Cell therapy for diabetic peripheral neurovascular complications
$6,139,029Young-Sup Yoon · Emory University · DP3 · FY2011 · DK
Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS)
$6,133,297Bjorn E Oskarsson · Mayo Clinic Jacksonville · U01 · FY2024 · NS
Gene Transfer And Ex Vivo Manipulation Of Stem Cells
$6,125,712Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
NIAAA Repository/Screening Database Management and Research
$6,107,809Melanie Schwandt · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2024 · AA
REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD
$6,107,805E Wesley Ely · Vanderbilt University Medical Center · R01 · FY2025 · AG
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
$6,099,975Luis J. Montaner · Wistar Institute · UM1 · FY2021 · AI
NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT
$6,091,219Norman Wolmark · Nsabp Foundation, Inc. · U10 · FY2009 · CA
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY
$6,064,830Keri, Hammel · The Emmes Company, Llc · N01 · FY2013 · EY
REPRIEVE - CCC - Lead Application
$6,060,885Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2014 · HL